Cargando…

Outcomes of intermediate-risk to high-risk stage I endometrial cancer: 10-year clinical experiences of using in-house multi-channel applicators in a single center

BACKGROUND: There are only very few reports on clinical outcomes using multi-channel applicators (MCA) for patients with endometrial cancer (EC) in China. We aimed to evaluate the clinical experience of treating intermediate-risk (IR) to high-risk (HR) stage I EC using in-house made multi-channel ap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hou, Xiao-Rong, Yu, Lang, Hu, Ke, Zhang, Fu-Quan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708688/ https://www.ncbi.nlm.nih.gov/pubmed/31365429 http://dx.doi.org/10.1097/CM9.0000000000000382

Ejemplares similares

Improving locoregional outcome in high-intermediate-risk and high-risk stage I endometrial cancer with surgical staging followed by brachytherapy
por: Abakay, Candan Demiroz, et al.
Publicado: (2022)

Role of systematic lymphadenectomy in patients with intermediate to high-risk early stage endometrial cancer
por: Kim, Nae Ry, et al.
Publicado: (2022)

Utilization Trend and Comparison of Different Radiotherapy Modes for Patients with Early-Stage High-Intermediate-Risk Endometrial Cancer: A Real-World, Multi-Institutional Study
por: Ren, Kang, et al.
Publicado: (2022)

Risk Factors and Prognosis of Early Recurrence in Stage I–II Endometrial Cancer: A Large-Scale, Multi-Center, and Retrospective Study
por: Dou, Yingyu, et al.
Publicado: (2022)

The Role of Para-Aortic Lymphadenectomy in the Surgical Staging of Women with Intermediate and High-Risk Endometrial Adenocarcinomas
por: May, Taymaa, et al.
Publicado: (2013)

Baseline risk of recurrence in stage I–II endometrial carcinoma
por: Sasada, Shinsuke, et al.
Publicado: (2018)

Laparoscopic surgery for low, intermediate and high-risk endometrial cancer
por: Vardar, Mehmet Ali, et al.
Publicado: (2018)

The Preeminent Value of the Apparent Diffusion Coefficient in Assessing High-Risk Factors and Prognosis for Stage I Endometrial Carcinoma Patients
por: Quan, Quan, et al.
Publicado: (2022)

Identifying a molecular profile to predict the risk of recurrence in high‐intermediate risk endometrial cancer
por: Arend, Rebecca C., et al.
Publicado: (2021)

Role of lymphadenectomy in intermediate-risk endometrial cancer: a matched-pair study
por: Coronado, Pluvio J., et al.
Publicado: (2018)

MRI-Based Radiomic Model for Preoperative Risk stratification in Stage I Endometrial Cancer
por: Chen, Jingya, et al.
Publicado: (2021)

Should the Optimal Adjuvant Treatment for Patients With Early-Stage Endometrial Cancer With High-Intermediate Risk Factors Depend on Tumor Grade?
por: Lan, Chunyan, et al.
Publicado: (2015)

Impact of vaginal brachytherapy in intermediate and high-intermediate risk endometrial cancer: a multicenter study from the FRANCOGYN group
por: Reboux, Pierre-Alain, et al.
Publicado: (2019)

Systematic lymphadenectomy for intermediate risk endometrial carcinoma treatment does not improve the oncological outcome
por: Candido, Elaine C., et al.
Publicado: (2019)

Squamous differentiation portends poor prognosis in low and intermediate-risk endometrioid endometrial cancer
por: de Andrade, Diocesio Alves Pinto, et al.
Publicado: (2019)

A 4-Gene Signature Associated With Recurrence in Low- and Intermediate-Risk Endometrial Cancer
por: de Andrade, Diocésio Alves Pinto, et al.
Publicado: (2021)

Recurrent patterns after postoperative radiotherapy for early stage endometrial cancer: A competing risk analysis model
por: Ren, Kang, et al.
Publicado: (2021)

Impact of different therapies on the survival of patients with stage I–IIA cervical cancer with intermediate risk factors
por: Nie, Jichan, et al.
Publicado: (2021)

Could the Long-Term Oncological Safety of Laparoscopic Surgery in Low-Risk Endometrial Cancer also Be Valid for the High–Intermediate- and High-Risk Patients? A Multi-Center Turkish Gynecologic Oncology Group Study Conducted with 2745 Endometrial Cancer Cases. (TRSGO-End-001)
por: Vardar, Mehmet Ali, et al.
Publicado: (2021)

Practice patterns of adjuvant radiotherapy in women with stage I to II endometrial carcinoma: a real-world multi-institutional analysis in China
por: Wang, Wenhui, et al.
Publicado: (2023)

Adjuvant Pelvic Radiotherapy vs. Sequential Chemoradiotherapy for High-Risk Stage I-II Endometrial Carcinoma
por: El-Hadaad, Hend Ahmed, et al.
Publicado: (2012)

A novel prediction score for predicting the baseline risk of recurrence of stage I–II endometrial carcinoma
por: Takahashi, Kenta, et al.
Publicado: (2018)

Type I error rates of multi-arm multi-stage clinical trials: strong control and impact of intermediate outcomes
por: Bratton, Daniel J., et al.
Publicado: (2016)

One-week vaginal brachytherapy schedule as exclusive adjuvant post-operative treatment in intermediate- and high-intermediate-risk endometrial cancer patients
por: De Sanctis, Vitaliana, et al.
Publicado: (2020)

Management of patients with intermediate-risk early stage cervical cancer
por: Cibula, David
Publicado: (2020)

Risk factors and sonographic endometrial thickness as predictors of tumour stage and histological subtype of endometrial cancer
por: Rizzuto, Ivana, et al.
Publicado: (2019)

Laparoscopic vs. open procedure for intermediate‑ and high‑risk endometrial cancer: a minimum 4-year follow-up analysis
por: Zhou, Xing, et al.
Publicado: (2022)

Avoiding Full Lymphadenectomies in Intermediate- and High-Risk Endometrial Cancer by Sentinel Lymph Node Biopsy Implementation
por: Pineda, Virginia García, et al.
Publicado: (2021)

Overview of adjuvant radiotherapy on survival, failure pattern and toxicity in stage I to II endometrial carcinoma: a long-term multi-institutional analysis in China
por: Wang, Wenhui, et al.
Publicado: (2022)

Adjuvant hormonal therapy for stage I endometrial cancer
por: Gien, L., et al.
Publicado: (2008)

Preoperative and intraoperative assessment of myometrial invasion in patients with FIGO stage I non-endometrioid endometrial carcinoma—a large-scale, multi-center, and retrospective study
por: Yang, Xiaohang, et al.
Publicado: (2023)

Assessment of Sentinel Lymph Node Biopsy vs Lymphadenectomy for Intermediate- and High-Grade Endometrial Cancer Staging
por: Cusimano, Maria C., et al.
Publicado: (2020)

The Role of Frozen Section in Surgical Staging of Low Risk Endometrial Cancer
por: Kumar, Sanjeev, et al.
Publicado: (2011)

Recurrence risk factors in stage IA grade 1 endometrial cancer
por: Nwachukwu, Chika, et al.
Publicado: (2021)

Relevance of pathologic features in risk stratification for early-stage endometrial cancer
por: Guerra, Esther, et al.
Publicado: (2021)

Comparison of Laparoscopy and Laparotomy for Para-Aortic Lymphadenectomy in Women With Presumed Stage I–II High-Risk Endometrial Cancer
por: Paik, E Sun, et al.
Publicado: (2020)

The “Sandwich” Schedule: A Well-Tolerated Adjuvant Treatment Both in Intermediate–High- and High-Risk Endometrial Cancer
por: Ferrero, Annamaria, et al.
Publicado: (2022)

Effectiveness of adjuvant systemic chemotherapy for intermediate-risk stage IB cervical cancer
por: Matsuo, Koji, et al.
Publicado: (2017)

Is invasive mediastinal staging necessary in intermediate risk patients with negative PET/CT?
por: Boada, Marc, et al.
Publicado: (2020)

Grade and stage misclassification in intermediate unfavorable‐risk prostate cancer radiotherapy candidates
por: Sorce, Gabriele, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_41bjtbcaopc3ufrat6cj64mpqe